{
 "PrintNo":"S9858","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2024-06-06T10:29:28.549243Z",
 "Status":"IN_SENATE_COMM","Committee":"Rules",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-06-06","Committee":"Rules"}],
 "Actions":[{"Text":"REFERRED TO RULES","Date":"2024-06-06","Chamber":"SENATE"}],
 "Sponsors":[{"ID":914,"Name":"Roxanne J. Persaud","Short":"PERSAUD"}],
 "Title":"Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients",
 "Summary":"Establishes a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients.",
 "LawSection":"Insurance Law","LawCode":"Amd ยง3238, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to establishing a mandated window of five business days for both Medicaid and private insurers to respond to pre-authorization claims for testing and/or treatments made by physicians on behalf of oncology patients",
 "SameAsPrintNo":"A10679-2023"
}